Breaking news on Avandia: the FDA this morning is limiting Avandia to patients with Type 2 diabetes whose condition cannot be controlled with other medications.
CNN also reports the European version of the FDA is recommending that Avandia be taken off the market. This decision must first be ratified by the EC.
The history of Avandia is a familiar one: Plaintiffs’ lawyers discover a problem and begin filing lawsuits. Drug company and industry supporters roll their eyes and decry the problem is greedy plaintiffs’ lawyers manufacturing lawsuits based solely on bad patient outcomes, not a defective drug. The attention spawned by the lawsuits leads to further investigation that shows that the drug is dangerous.